Scandinavian Phase 3 Trial Finds Aspirin Does Not Prevent Colorectal Cancer Recurrence After Liver Metastasis Treatment
A large Scandinavian phase 3 clinical trial has found that starting aspirin after curative-intent treatment for colorectal cancer that has spread to the liver does not reduce the risk of cancer recurrence or death. The findings come from the ASAC trial, conducted across hospitals in Norway, Sweden and Denmark.











